The morality and ethics governing CRISPR-Cas9 patents in China.
Institute for Globalization and International Regulation, Maastricht University, Maastricht, the Netherlands.
Yaojin
Y
Peng
D002681:China; D002986:Clinical Trials as Topic / Q000941:ethics / Q000331:legislation & jurisprudence; D064112:Clustered Regularly Interspaced Short Palindromic Repeats / Q000235:genetics*; D000072669:Gene Editing / Q000941:ethics* / Q000331:legislation & jurisprudence*; D015316:Genetic Therapy / Q000941:ethics* / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D028701:Patient Rights / Q000941:ethics* / Q000331:legislation & jurisprudence